RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
103 hedge funds and large institutions have $1.04B invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 5 closing their positions.
Holders
103
Holders Change
+29
Holders Change %
+39.19%
% of All Funds
1.63%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
34
Increased
27
Reduced
30
Closed
5
Calls
$5.38M
Puts
–
Net Calls
+$5.38M
Net Calls Change
-$1.93M
Top Buyers
| 1 |
BC
1
Boxer Capital
San Diego,
California
|
$64.7M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$37.3M |
| 3 |
3
Norges Bank
Oslo,
Norway
|
$33.5M |
| 4 |
4
Goldman Sachs
New York
|
$11.2M |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$9.32M |
